Treatment of Allergic Conjunctivitis with Nasal and Sinus Congestion in Young Patients

First-Line Systemic Treatment for Combined Nasal and Ocular Symptoms

The American Academy of Allergy, Asthma, and Immunology recommends initiating combination therapy with an intranasal corticosteroid plus an intranasal antihistamine for both nasal and ocular symptoms, supplemented with topical dual-action ophthalmic agents if ocular symptoms require additional control 1, 2, 3
Intranasal corticosteroids are the cornerstone of therapy because they effectively treat both nasal congestion and associated ocular symptoms with similar efficacy to oral antihistamines for eye symptoms 1, 2, 3
Adding an intranasal antihistamine to the intranasal corticosteroid provides over 40% relative improvement over either agent alone and is the most effective pharmacologic therapy available 4
Oral antihistamines can relieve ocular symptoms associated with rhinitis but are generally less effective than topical ophthalmic agents and have slower onset of action 2, 3, 5
Oral decongestants can be added to reduce nasal congestion, though they may cause insomnia, loss of appetite, irritability, and palpitations 6

Cold compresses and saline irrigation or artificial tears should be used first for mild symptoms of allergic conjunctivitis 2, 3, 7
Topical dual-action ophthalmic agents are preferred for moderate to severe ocular symptoms because they have onset of action within 30 minutes and are suitable for both acute and longer-term treatment 5
Available dual-action agents include azelastine, epinastine, ketotifen, and olopatadine 5
Topical antihistamine/vasoconstrictor combinations work better than either agent alone for acute relief, though vasoconstrictors only relieve redness without reducing the allergic response 2, 3, 5
Limit topical decongestants to 10 days maximum to avoid rebound hyperemia 2, 3, 7

In children under 3 years, avoid oral decongestants and antihistamines due to possible adverse effects 8
Intranasal sprays must be directed away from the nasal septum to maximize efficacy and minimize local side effects 4

Do not use montelukast as primary therapy for allergic rhinitis, as it is significantly less effective than intranasal corticosteroids 4
Do not prescribe antibiotics for allergic rhinoconjunctivitis, as symptoms like mucopurulent nasal discharge can occur in noninfectious rhinitis, and antibiotics are ineffective for allergic conditions 2, 3, 7, 8
Avoid prolonged use of topical ocular corticosteroids except for severe refractory cases, as they can cause vision-threatening complications 5

Assess for comorbid conditions including asthma, atopic dermatitis, sleep-disordered breathing, rhinosinusitis, and otitis media, as these require concurrent management 9
Consider allergen-specific immunotherapy for persistent severe cases refractory to conventional treatment, as it can benefit both rhinitis and conjunctivitis and may prevent development of asthma and new allergen sensitivities in children 2, 3, 9
Environmental modification and allergen avoidance measures should be implemented for all patients alongside pharmacologic therapy 4
Verify diagnosis with specific IgE testing if not already performed to confirm allergic etiology and identify specific allergen triggers 4